<DOC>
	<DOCNO>NCT01543022</DOCNO>
	<brief_summary>The Counter Pulsation Device ( CPD ) System 'Symphony ' intend provide counter pulsation therapy thirty ( 30 ) day patient chronic heart failure persistent worsen condition despite optimal medical therapy . Patients New York Heart Association ( NYHA ) Class IIIb IV heart failure exhaust medical surgical option .</brief_summary>
	<brief_title>Symphony : The Implantable Counter Pulsation Device ( CPD ) Safety Feasibility Trial</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<criteria>1 . New York Heart Association Class IIIB IV heart failure despite optimal medical therapy , include ACE inhibitor , beta blocker , IV diuretics pressor 2 . Left Ventricular Ejection Fraction &lt; 40 % . 3 . Patient candidate conventional catheterbased surgical intervention valve intervention coronary artery bypass surgery . 4 . Patient currently candidate heart transplantation placement leave ventricular assist device ( LVAD ) bridge heart transplantation due comorbidities . Patients may become candidate option improvement device due improve cardiac output . 5 . Patients exhaust approved surgical medical therapy determine heart failure cardiologist surgeon expertise heart failure . 6 . Patient evaluate multidisciplinary research team felt suitable candidate research study . The final decision regard patient 's candidacy research remain attending cardiologist heart surgeon . 7 . Improved hemodynamics device support allow potential physical rehabilitation . 8 . Signed Informed Consent , oral informed consent write confirmation uninvolved third party 9 . Age subject least 19 year 1 . High likelihood death current hospitalization ( judged attend physician ) condition heart failure would limit survival less two year . 2 . Require mechanical ventilation . 3 . Failure wean IABP , Impella , ECMO mode circulatory support . 4 . Complex arrhythmia negatively impact effectiveness counter pulsation . 5 . Dependency high dose inotropes . 6 . Cerebrovascular accident TIA within previous 3 month . 7 . Contraindication anticoagulation medication Heparin , Coumadin , Aspirin Plavix . 8 . Presence hypercoaguable state history idiopathic venous arterial thrombosis . 9 . Severe calcification target vessel preclude insertion Symphony device . 10 . Moderate severe aortic insufficiency ( 2+ ) . 11 . Ongoing systemic infection define two following : WBC &gt; 12,500 positive blood culture fever 12 . Abnormal prealbumin ( &lt; 13mg/dL ) , albumin ( &lt; 3.0 mg/dl ) 13 . A cardiac rhythm use trigger CPD ( sinus rhythm , ventricular atrial pacing , AV pace ) . 14 . Abnormal bilateral carotid Doppler CT exam define &gt; 50 % stenosis . 15 . Subclavian artery internal diameter &lt; 7 mm Doppler study CT exam . 16 . Ability ambulate &lt; 200 metre 6 minute walk test . 17 . Any aortic aneurysmal disease . 18 . Active document HIT . 19 . Presence mechanical heart valve . 20 . Moderate severe RV failure . 21 . Severe tricuspid regurgitation . 22 . History major psychiatric illness . 23 . Endorgan dysfunction include : renal failure define serum Cr &gt; 2.5 mg/dl , liver dysfunction define bilirubin 2X normal , elevate INR anticoagulation , respiratory failure define FEV1 &lt; 50 % predict . 24 . Chest Xray rule pulmonary pathology increase risk need treatment prior device implant . 25 . BMI &gt; 40 kg/ m2 . 26 . Active participation another clinical trial may interfere trial .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
</DOC>